EFFICACY AND SAFETY RESULTS OF ATRASENTAN IN PATIENTS WITH IGA NEPHROPATHY ON SODIUM‚ÄÌGLUCOSE CO-TRANSPORTER 2 INHIBITORS: PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL (ASSIST)